Abstract
The national and international demand for stem cell lines of varying origins (eg human embryonic, induced pluripotent, somatic) and grades (eg research, clinical) is growing. This is in response to the expectation that stem cell science will radically improve our ability to understand and treat disease, to develop model systems of drug development, and to generate novel clinical therapies. A sustainable supply of stem cell lines that are scientifically and ethically sourced is both a practical and legal prerequisite for the continued progression of stem cell research towards clinical therapies. To this end, stem cell banks have become an invaluable resource, providing access to ethically sourced stem cell lines that meet high quality and safety standards.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 35-39 |
| Number of pages | 5 |
| Journal | Drug Discovery World |
| Volume | 13 |
| Issue number | 2 |
| State | Published - Mar 1 2012 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Drug Discovery
Cite this
Stem cell banks : Investing in the promise of cancer stem cell science. / Page, Madeline; Isasi, Rosario.
In: Drug Discovery World, Vol. 13, No. 2, 01.03.2012, p. 35-39.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Stem cell banks
T2 - Investing in the promise of cancer stem cell science
AU - Page, Madeline
AU - Isasi, Rosario
PY - 2012/3/1
Y1 - 2012/3/1
N2 - The national and international demand for stem cell lines of varying origins (eg human embryonic, induced pluripotent, somatic) and grades (eg research, clinical) is growing. This is in response to the expectation that stem cell science will radically improve our ability to understand and treat disease, to develop model systems of drug development, and to generate novel clinical therapies. A sustainable supply of stem cell lines that are scientifically and ethically sourced is both a practical and legal prerequisite for the continued progression of stem cell research towards clinical therapies. To this end, stem cell banks have become an invaluable resource, providing access to ethically sourced stem cell lines that meet high quality and safety standards.
AB - The national and international demand for stem cell lines of varying origins (eg human embryonic, induced pluripotent, somatic) and grades (eg research, clinical) is growing. This is in response to the expectation that stem cell science will radically improve our ability to understand and treat disease, to develop model systems of drug development, and to generate novel clinical therapies. A sustainable supply of stem cell lines that are scientifically and ethically sourced is both a practical and legal prerequisite for the continued progression of stem cell research towards clinical therapies. To this end, stem cell banks have become an invaluable resource, providing access to ethically sourced stem cell lines that meet high quality and safety standards.
UR - http://www.scopus.com/inward/record.url?scp=84860774377&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860774377&partnerID=8YFLogxK
M3 - Review article
AN - SCOPUS:84860774377
VL - 13
SP - 35
EP - 39
JO - Drug Discovery World
JF - Drug Discovery World
SN - 1469-4344
IS - 2
ER -